XNAS · ASBP
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Aspire Biopharma Holdings, Inc. Common Stock

Aspire Biopharma Holdings, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$7.97
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Analyst data unavailable at compute time
ASBP
Aspire Biopharma Holdings, Inc. Common Stock
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ASBP moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ASBP catalysts
About Aspire Biopharma Holdings, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2025
Country
US

Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$7.97
Last session
Day high
$7.97
Last session
Day low
$7.97
Last session
Previous close
$7.97
52W high
$702.96
-98.87% from high
52W low
$4.65
0% of range
Market cap
$11.2M
EPS
$-29.1067
Beta
3.86
Shares out
1.4M
Avg volume
42.1K
VWAP
$7.97
Last session
Price history computed in-house
1W
+2.97%
1M
+9.78%
3M
+57.20%
1Y
-98.78%
YTD
-94.96%
SMA 50 $6.66 · above
SMA 200 $50.15 · below
52W position 0%

ASBP overview

Veridion Score
59
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ASBP.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ASBP Form 4 filings
Public disclosures

Congress activity in ASBP

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for ASBP in the cached public ledger.

Federal contracts

ASBP contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ASBP in this window.
Lobbying spend

ASBP lobbying filings, year to date.

Registered lobbying filings matched to Aspire Biopharma Holdings, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ASBP in this window.
Loading news for ASBP
Analyst ratings
Sovereign unlock shows live analyst consensus for ASBP.
Options
Sovereign unlock shows live options positioning for ASBP.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.